(Q37176506)

18 August 2017

1 reference

title

New assays for monitoring haemophilia treatment (English)

1 reference

18 August 2017

0 references

M Shima

1

1 reference

18 August 2017

T Matsumoto

series ordinal

2

1 reference

18 August 2017

K Ogiwara

series ordinal

3

1 reference

18 August 2017

publication date

1 July 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

14 Suppl 3

1 reference

18 August 2017

page(s)

83-92

1 reference

Phenotypic heterogeneity in severe hemophilia

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01737.X

Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01737.X

Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01737.X

Thrombelastography/thromboelastometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01737.X

Platelet activity of high-dose factor VIIa is independent of tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01737.X

Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01737.X

A thrombin generation test; the application in haemophilia and thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01737.X

A simple method of studying the generation of thrombin in recalcified plasma; application in the investigation of haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01737.X

Calibrated automated thrombin generation measurement in clotting plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01737.X

Efficient lentiviral transduction of liver requires cell cycling in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01737.X

Potential role of the dynamic properties of whole blood coagulation in assessment of dosage requirements in haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01737.X

Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01737.X

Thrombin generation and phenotypic correlation in haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01737.X

The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01737.X

Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01737.X

A modified thrombin generation test for the measurement of factor VIII concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01737.X

Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01737.X

Effect of standardization and normalization on imprecision of calibrated automated thrombography: an international multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01737.X

Towards a standardization of thrombin generation assessment: the influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01737.X

Unresponsiveness to factor VIII inhibitor bypassing agents during haemostatic treatment for life-threatening massive bleeding in a patient with haemophilia A and a high responding inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01737.X

Understanding the hemostatic effects of recombinant factor VIIa by clot wave form analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01737.X

Major surgery in a severe haemophilia A patient with high titre inhibitor: use of the thrombin generation test in the therapeutic decision.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01737.X

Effectiveness of factor VIII infusions in haemophilia A patients with high responding inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01737.X

Higher recovery of factor VIII (FVIII) with intermediate FVIII/von Willebrand factor concentrate than with recombinant FVIII in a haemophilia A patient with an inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01737.X

Impact of different inhibitor reactivities with commercial factor VIII concentrates on thrombin generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01737.X

10.1111/J.1365-2516.2008.01737.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference